These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1144 related items for PubMed ID: 17255126

  • 1. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 3. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 4. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
    Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM.
    Arch Intern Med; 2010 Jun 28; 170(12):1045-9. PubMed ID: 20585070
    [Abstract] [Full Text] [Related]

  • 5. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 28; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 6. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E, Camerini C, Gaggia P, Zubani R, Cancarini G.
    Am J Nephrol; 2018 Mar 28; 48(2):79-86. PubMed ID: 30071530
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
    Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.
    Diabet Med; 2007 May 28; 24(5):486-93. PubMed ID: 17367311
    [Abstract] [Full Text] [Related]

  • 8. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ, Smith SM, Choksi R.
    Expert Rev Cardiovasc Ther; 2009 Nov 28; 7(11):1373-84. PubMed ID: 19900020
    [Abstract] [Full Text] [Related]

  • 9. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC, Figueiredo AE, Barretti P, Pecoits-Filho R, de Moraes TP, BRAZPD Investigators.
    Am J Nephrol; 2017 Nov 28; 46(2):150-155. PubMed ID: 28738355
    [Abstract] [Full Text] [Related]

  • 10. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A.
    Expert Rev Cardiovasc Ther; 2008 Jun 28; 6(5):759-71. PubMed ID: 18510491
    [Abstract] [Full Text] [Related]

  • 11. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA.
    Cardiovasc Ther; 2012 Jun 28; 30(3):e156-66. PubMed ID: 21883995
    [Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients.
    Lin HH, Yang YF, Chang JK, Ting IW, Kuo HL, Wang IK, Huang CC.
    Ren Fail; 2009 Jun 28; 31(10):942-5. PubMed ID: 20030530
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar 28; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 28; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 15. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
    Ozturk S, Sar F, Bengi-Bozkurt O, Kazancioglu R.
    Kidney Blood Press Res; 2009 Mar 28; 32(4):268-75. PubMed ID: 19776644
    [Abstract] [Full Text] [Related]

  • 16. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2005 Mar 28; 37(2):991-3. PubMed ID: 15848600
    [Abstract] [Full Text] [Related]

  • 17. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT.
    J Am Board Fam Med; 2009 Mar 28; 22(6):686-97. PubMed ID: 19897698
    [Abstract] [Full Text] [Related]

  • 18. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D, Vesterman-Landes J, Bialik M, Katzir I, Lomnicky Y, Halkin H, Loebstein R.
    Clin Ther; 2011 Apr 28; 33(4):456-64. PubMed ID: 21635991
    [Abstract] [Full Text] [Related]

  • 19. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA.
    Nephrol Dial Transplant; 2009 May 28; 24(5):1663-71. PubMed ID: 19145003
    [Abstract] [Full Text] [Related]

  • 20. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
    Robles NR, Cancho B, Barroso S, Martín MV, Sánchez Casado E.
    Int J Clin Pract; 2006 Sep 28; 60(9):1035-9. PubMed ID: 16939543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.